Details for New Drug Application (NDA): 050673
✉ Email this page to a colleague
NDA 050673 describes CECLOR CD, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the CECLOR CD profile page.
The generic ingredient in CECLOR CD is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
The generic ingredient in CECLOR CD is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
Medical Subject Heading (MeSH) Categories for 050673
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 375MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jun 28, 1996 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Jun 28, 1996 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
